Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all ...

NHS patients in England will be among the first in the world to receive Gilead’s Tecartus cancer cell therapy for certain types of lymphoma, after the company’s specialist Kite unit struck a ...

Emails between Nishihira and Dignity Project lead Duenas, presented by Travis, reflect the three requests for quote. “We were only required to do one,” Nishihira noted. Travis asked how ...

We’ve all had moments when we wished we’d handled our emotions differently—whether in the classroom, a staff meeting, or at home. And we’ve all seen students overwhelmed by big emotions ...